Marker Guided Breathhold Radiotherapy in NSCLC
NCT02447900 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2021-01-29
Summary
Proof of concept study evaluating safety and performance of a gel marker (BioXmark) used for image guidance in deep inspiration breathhold radiotherapy (DIBH IGRT) in patients with locally advanced non-small cell lung cancer (NSCLC)
Conditions
Interventions
- DEVICE
-
BioXmark
Sponsors & Collaborators
-
Steen Riisgaard Mortensen
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
Biomarkers for Prediction of Tumor Response to Radiotherapy
NCT03744819 ·Status: RECRUITING
-
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
NCT04081428 ·Status: ACTIVE_NOT_RECRUITING
-
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
NCT04686500 ·Status: COMPLETED ·Phase: NA
-
Evaluation of RFID Localization System for Marking and Retrieving Breast Lesions
NCT01574664 ·Status: WITHDRAWN
-
Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
NCT04788147 ·Status: COMPLETED ·Phase: NA
-
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
NCT06487403 ·Status: RECRUITING ·Phase: NA
-
DIBH Proton Planning
NCT01386697 ·Status: COMPLETED
-
Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
NCT05609331 ·Status: TERMINATED ·Phase: NA
-
Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients
NCT01859650 ·Status: COMPLETED
-
Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer
NCT05804916 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials
NCT00500513 ·Status: COMPLETED ·Phase: NA
-
Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
NCT00232440 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule
NCT02916394 ·Status: UNKNOWN ·Phase: NA
-
LungPoint ATV for Biopsy in Patients Undergoing Lobectomy
NCT02130115 ·Status: COMPLETED ·Phase: NA
-
Assessment of 2 Different Techniques for Suppression of Respiratory Motion in Lung Cancer Treatment With Proton Therapy Using Magnetic Resonance Imaging (MRI)
NCT03669341 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the Lung
NCT04060927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Displacement Distance and Stabilization Time for Liver Fiducial Marker
NCT05816837 ·Status: UNKNOWN
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
NCT00551369 ·Status: COMPLETED ·Phase: PHASE2
-
Continuing Evaluation of the LungPoint ATV System
NCT02130128 ·Status: TERMINATED ·Phase: NA
-
Implantation of Markers for the Radiotherapy of Lung Cancer Patients
NCT00856427 ·Status: TERMINATED ·Phase: PHASE1
-
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
NCT02379039 ·Status: COMPLETED
-
Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy
NCT03623334 ·Status: COMPLETED ·Phase: NA
-
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC
NCT00246181 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tumor Motion Management in Radiotherapy Using 4D-MRI
NCT01934855 ·Status: COMPLETED
-
Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis
NCT04414293 ·Status: UNKNOWN ·Phase: NA